Cibus Inc (NAS:CBUS)
$ 5.28 0.875 (19.89%) Market Cap: 139.28 Mil Enterprise Value: 123.72 Mil PE Ratio: 0 PB Ratio: 0.37 GF Score: 60/100

Cibus Inc at Canaccord Genuity Growth Conference Transcript

Aug 09, 2023 / 04:30PM GMT
Release Date Price: $20.49 (-2.10%)
Bobby Burleson
Canaccord Genuity - Analyst

Great. Thanks for being with us. We have Cibus. This is a company that is doing a lot to accelerate the commercialization of bringing advanced traits to row crops, and they're focused on some pretty big markets. They've got access to some of the best germplasm out there.

And with that, I'll turn it over to CEO Rory Riggs to give you the full presentation, then we'll do some Q&A. Thanks.

Rory Riggs
Cibus, Inc. - Co-Founder, CEO & Chairman

Thanks. We're indebted to Bobby because he wrote about us early on, so we totally appreciate it. I was going to talk about how cool this was, that this was like our first roadshow for us going public. Then I realized that what I really have to say is, I'm Calyxt, your former client transformed. And we're totally complimentary of all the stuff that came from Calyxt, regardless of having a business decision -- they have amazing technology that, with us, the two companies together really own virtually all the important patents and technology in gene editing and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot